NEU 0.45% $20.00 neuren pharmaceuticals limited

conference starts today, page-5

  1. 13 Posts.
    lightbulb Created with Sketch. 1
    7 March Washington
    9:40 Development of a Novel Neuroprotective Molecule for Mild TBI/Concussion
    In this presentation Mr. Glass will discuss the product development pathway for a neuroprotectant molecule from discovery through early-stage clinical trials. The presentation will cover discovery, pharmacology, oral formulation development, regulatory strategy and clinical trial considerations for NNZ-2566, a synthetic analog of the naturally occurring neuropeptide, IGF-1(1-3).

    Larry Glass, Chief Executive Officer, Neuren Pharmaceuticals


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.00
Change
0.090(0.45%)
Mkt cap ! $2.556B
Open High Low Value Volume
$19.88 $20.07 $19.73 $11.80M 591.1K

Buyers (Bids)

No. Vol. Price($)
2 5901 $19.97
 

Sellers (Offers)

Price($) Vol. No.
$20.00 3262 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.